Summit Partners Public Asset Management, LLC Sarepta Therapeutics, Inc. Transaction History
Summit Partners Public Asset Management, LLC
- $2.79 Billion
- Q3 2024
A detailed history of Summit Partners Public Asset Management, LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Summit Partners Public Asset Management, LLC holds 138,118 shares of SRPT stock, worth $15.3 Million. This represents 0.62% of its overall portfolio holdings.
Number of Shares
138,118
Previous 21,318
547.89%
Holding current value
$15.3 Million
Previous $3.37 Million
412.17%
% of portfolio
0.62%
Previous 0.15%
Shares
12 transactions
Others Institutions Holding SRPT
# of Institutions
531Shares Held
84.5MCall Options Held
2.06MPut Options Held
1.52M-
Black Rock Inc. New York, NY10.3MShares$1.14 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.97MShares$994 Million0.02% of portfolio
-
Capital International Investors Los Angeles, CA6.26MShares$694 Million0.16% of portfolio
-
Janus Henderson Group PLC London, X04.36MShares$483 Million0.29% of portfolio
-
State Street Corp Boston, MA4.27MShares$473 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $9.71B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...